May 19, 2021 ERA4TB Update NEWSLETTER: The ERA4TB (European Regimen Accelerator for Tuberculosis) project, a public-private initiative devoted
May 18, 2021 C-Path Request for Proposal for External Communications Critical Path Institute (C-Path) is seeking a proposal, including timelines and budget, for external marketing, communications, pu
April 22, 2021 Data Collaboration Center Request for Proposal RFP: The RDCA Branding & Web Portal Data Collaboration Center’s (DCC’s) platform development team is seeking a proposal, i
April 14, 2021 CPTA Welcomes Triplet Therapeutics Chief Medical Officer as Industry Co-Director C-Path’s Critical Path to Therapeutics for the Ataxias Consortium is pleased to announce the appointment of Irina Antonijevi
April 8, 2021 CP-SCD Announces Pfizer Executive as its First Industry Co-Director C-Path’s Critical Path to Sickle Cell Disease Consortium (CP-SCD) is pleased to announce Dr. David Readett of Pfizer as its firs
April 6, 2021 C-Path Welcomes Dr. Ramona Belfiore Oshan as D-RSC Associate Director C-Path is pleased to welcome Ramona Belfiore Oshan, Ph.D., as the new Associate Director for its Duchenne Regulatory Science
March 31, 2021 Cures Within Reach Names CURE ID as 2021 Patient Impact Awardee Cures Within Reach, a global nonprofit leading the use of repurposing research to help improve patients’ lives, has a
March 31, 2021 Introducing Dr. Alexandre Bétourné, RDCA-DAP Scientific Director C-Path is pleased to welcome Alexandre Bétourné, PhD, PharmD, as its new Scientific Director for the Rare Disease Cures Accelera
March 18, 2021 Welcome Dr. Martijn Muller as CPP Senior Scientific Director C-Path is pleased to welcome Martijn Muller, PhD, as Senior Scientific Director for the Critical Path for Parkinson Consortium. Pr
February 17, 2021 C-Path’s Data Collaboration Center Seeks Proposals The Critical Path Institute Data Collaboration Center is seeking proposals for the creation of non-identifiable, synthetic patient